Welcome to the Dew Sweeper, your one-stop shop to catch up on the weekend action from the golf world. From the professional tours, trending news, social media headlines and upcoming events, here's every golf-related thing you need to know for the morning of Oct. 28.
Tiger ties Snead
The greats can make the routine spectacular, and the spectacular seem routine. In a tournament halfway around the world, during a time most golf fans are in hibernation, we were reminded, once again, no one in modern sports personifies that sentiment like Tiger Woods.
Woods, making his first appearance in two months and first since his fifth career knee surgery, won the inaugural Zozo Championship in Japan by three shots over Hideki Matsuyama. A win, his 82nd on the PGA Tour, that ties Sam Sneads all-time record.
Its about being consistent and doing it for a long period of time, Woods said. Ive been very fortunate to have the career Ive had so far.
A rain-out on Friday made the weekend a marathon, a dash that was held in the waning hours of Americas East Coast. Yet Woods, who shared the first-round lead with Gary Woodland with a 64, never relinquished his position, entering Monday morning with a three-shot lead over Matsuyama with seven holes left to play.
Woods opened with a bogey at Narashino Country Clubs 12thlet the record show his first-hole jitters apply to restarts as wellbut negated the mistake with a birdie at the 14th. Woods followed with three pars before making an up-and-down birdie, and taking a final-bow fist pump, at the 18th.
The scene was not as visceral or breathtaking as East Lake, the moment not as cathartic or emotional as Augusta. When you win 82 times, all will not be made-for-movie scripts. Even so, Woods made history when few expected him to, in a workman-like manner that belied its blowout fashion. He continues to pen a story no screenwriter could conjure.
The only thing apropos about his performance was his fondness for proving critics wrong. As early as last week, some wondered if Woods was transitioning into the ceremonial player phase of his career. Suppose thats partially true; trophies are handed out at ceremonies, after all.
Its satisfying to dig my way out of it and figure it out, figure out a way, Woods said. There are some hard times to figure it out, but Ive come back with different games over the years.
And perhaps, for years to come.
Tiger the player impresses Tiger the captain
Speaking of future, Woods' next likely appearance will be at his Hero World Challenge in December after the end of the tour's fall slate. The following week is the Presidents Cup, which Woods is captaining for the United States. Though the 43-year-old was not among the eight automatic qualifiers, he remains a consideration for one of the four spot remaining for captain's picks.
A spot he has appeared to lock up.
I think I certainly, as a player, got the captain's attention, Woods jokingly said at his post-round press conference.
Or, as Woodlandalso a captain's pick candidateframed it: "If he doesnt [pick himself], hes dumb.
Woods has made eight Presidents Cup appearances in his career, the last coming in 2013. His picks are expected to come in the first week of November.
The 2019 Presidents Cup will be played at Royal Melbourne, the site of the only International victory in Presidents Cup history (1998). The biennial event begins Dec. 12.
McCord, Kostis out at CBS
Two mainstays of CBS Sports' golf broadcast team are not returning in 2020.
The contracts of Gary McCord and Peter Kostis have not been renewed for next season by the network. Golfweek's Geoff Shackelford and Sports Business Journal's John Ourand reported the news on Saturday, and CBS confirmed the move to Golf Digest in a statement.
"Gary and Peter have been an important part of our golf coverage for three decades," said a CBS spokesperson. "They were both outstanding teammates, and we thank them for their significant contributions throughout the years. We wish them both all the best.
Kostis had been with CBS since 1992, working as an on-course reporter. He is most known for his breakdowns of player swings in slow-motion sequences. McCord, a former PGA Tour player, joined CBS in 1986. He rose to prominence thanks to a colorful personality, one that occasionally got him into trouble, most notably earning a ban from broadcasting at the Masters for saying "There are some body bags down there if that keeps going," when a ball was rolling toward a water hazard, and joking that "bikini wax" was used on Augusta National's greens.
CBS Sports' next broadcast is the 2020 Farmers Insurance Open at Torrey Pines in late January. The network's contract with the PGA Tour ends in 2021, although CBS is one of multiple entities currently bidding for future media rights.
Surprise winner in Euro Tour finale
Steven Brown was using the Portugal Masters to prepare for an upcoming trip to the European Tour's Qualifying tournament. His itinerary post-Portugal has dramatically changed.
Entering the week 150th in the Race to Dubai standings, Brown played bogey-free over his last 36 holesincluding a five-under final round at Dom Pedro Victoria Golf Courseto win the Euro Tour regular-season finale by one over Branden Stone and Justin Walters.
The victory means instead of fighting for his tour card in Q-school for the seventh time in eight years, Brown has earned an invite to the postseason, beginning in two weeks at the Turkish Airlines Open.
"You just never know with this game," Brown said. "It's crazy to think how well I've played the last month to how bad it was the first two-thirds of the year. I never thought this was going to happen Even today, I liked the fact that I had to go for it and I wasn't just trying to have a good result. That's probably the difference."
Also gaining entry into the playoffs (the top 115 in the Race to Dubai rankings advance) was Walters, who began the week at No. 124. Some of the bubble boys who didn't fare so well were Paul Dunne, former Ryder Cup player Jamie Donaldson and Lee Slattery. Slatterys ousting was particularly brutal, as he missed the cut by a shot seven times in 2019.
Koepka (knee) to miss more time
The worlds best will be at the first WGC of the 2019-'20 PGA Tour season this week. But the World No. 1 will not.
Brooks Koepka was not among the field commitments to the HSBC Champions on Friday. Koepka aggravated his left knee after slipping on wet concrete during the CJ Cup two weeks ago in South Korea, withdrawing from the event and returning to the United States for further testing. He dropped out of the Zozo Championship in the process yet left open the possibility of playing in the WGC-HSBC.
That Koepka is staying on the sidelines is not a surprise. Following the Tour Championship, Koepka underwent stem-cell treatment to repair a partially torn patella tendon in that same knee, a procedure he referred to as extremely painful. He missed the cut in his first tournament back at the Shriners Hospital for Children Open, and indicated in South Korea another stem-cell treatment is on the table.
Koepka is likely out for the remainder of the PGA Tours fall slate, and his involvement for Decembers Presidents Cup is in question. Tiger Woods, who will captain the United States team, said earlier last week hes been in talks with Brooks about the matter.
Were just waiting to see what the surgeons say and see what his protocols will be going forward. Thats something hell keep me abreast of going forward, Woods said. Hes getting other opinions about where his knee is and what his options are. I went through the same thing with my knee and my back. You want as many opinions as you can before you decide which road you want to go down.
WATCH: GOLF DIGEST VIDEOS
- Aspen Neuroscience gets funding to pursue personalized cell therapy for Parkinsons disease - The San Diego Union-Tribune - December 14th, 2019
- Acute Leukemia: 5 Things to Know - Medscape - December 14th, 2019
- Global T-Cell Therapy (CAR T-Cell, Tumor Infiltrating Lymphocytes) Market Size, Share & Trends Analysis Report 2019-2026 - ResearchAndMarkets.com... - December 14th, 2019
- CAMPUS: EGG DONATION - Artificial sperm cells to remove the genetic worries of sperm donation - ESHRE - December 14th, 2019
- Stem Cell Therapy Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2045 2017 - 2025 - Markets Gazette 24 - December 14th, 2019
- Aspen Neuro Bags $6.5M to Test Parkinson's Disease Stem Cell Therapy - Xconomy - December 13th, 2019
- LentiGlobin Gene Therapy Continues to Show Promising Results in SCD, Updated Trial Data Shows - Sickle Cell Anemia News - December 13th, 2019
- CHMP Issues Positive Opinion Recommending DARZALEX (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple... - December 13th, 2019
- Treatment Characteristics and Outcomes for Patients With Rare Forms of T-Cell Lymphoma - Hematology Advisor - December 13th, 2019
- Researchers ID Molecule that Appears to Halt and Reverse Scarring in Fibrotic Diseases - BioSpace - December 13th, 2019
- Canine Stem Cell Therapy Market with Future Prospects, Key Player SWOT Analysis and Forecast To 2024 - Tech Estate Today - December 13th, 2019
- StemGenex - Stem Cell Therapy, Stem Cell Treatments, Stem ... - December 11th, 2019
- Cutting Edge Exosome Regenerative Therapy Comes to Yelm's AM Medical - ThurstonTalk - December 11th, 2019
- Sickle Cell Disease: Ex Vivo Cell Therapy Shines in Early Study - MedPage Today - December 11th, 2019
- Five recent drug target discoveries for pancreatic cancer - Drug Target Review - December 11th, 2019
- Immunotherapy drug improves outcomes for some children with relapsed leukemia - National Institutes of Health - December 11th, 2019
- 20(R)-Ginsenoside Rg3 Influences Cancer Stem Cell Properties and the E | OTT - Dove Medical Press - December 11th, 2019
- Patients closer to receiving regenerated tissue, scientists say - The Irish News - December 11th, 2019
- The Knesset dissolves and the public suffers - Ynetnews - December 11th, 2019
- Global T-Cell Therapy Market: Trends, Opportunities and Forecasts (2019-2026) - Therapy for Solid Tumors Expected to Emerge as a Lucrative Source of... - December 11th, 2019
- Layoffs at Fla.-based stem cell clinic accused of aggressively marketing patients - ABC Action News - December 11th, 2019
- Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of US Patent for Method of Generating Induced Pluripotent Stem Cells - BioSpace - December 11th, 2019
- New Mechanism of Bone Maintenance and Repair Discovered - Technology Networks - December 11th, 2019
- BMS' oral maintenance therapy boosts survival in AML patients - PMLiVE - December 11th, 2019
- Autoimmune Technologies Announces New Subsidiary to Develop Novel Antibody and Allogeneic Somatic Stem Cell Therapeutics For the Treatment of Invasive... - December 10th, 2019
- Microbial Dynamics in Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation - Oncology Nurse Advisor - December 10th, 2019
- CStone's anti-PD-L1 antibody demonstrates promising antitumor activity with a complete response rate of 33.3% and a good safety profile in patients... - December 10th, 2019
- Celularity Presents Pre-Clinical and Clinical Data from its Allogeneic, Placental-Derived, Off-the-Shelf Cell Therapy Platform at the 2019 ASH Annual... - December 10th, 2019
- Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug... - December 10th, 2019
- Novartis sets 2020 target for commercial readiness of cell therapy CMO - BioPharma-Reporter.com - December 10th, 2019
- Stadius Biopharma to Present Data on Fully Human Antibodies for the Treatment of Candida Infections - P&T Community - December 10th, 2019
- Seattle Genetics and Takeda Announce Additional Analyses of ADCETRIS (Brentuximab Vedotin) ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials at the 2019... - December 10th, 2019
- ASH 2019: Second-gen CAR T-Cell Therapy Overcome Resistance, Reduce Toxicity and Simplify Treatment - OncoZine - December 10th, 2019
- IFN-: The T cell's license to kill stem cells in the inflamed intestine - Science - December 8th, 2019
- Movies opening in L.A. this week: 'Bombshell,' 'Jumanji: The Next Level' and more - Los Angeles Times - December 8th, 2019
- Updated Clinical Data from Phase 2 SPiReL Study Evaluating DPX-Survivac as a Combination Therapy in r/r DLBCL Presented at 61st American Society of... - December 8th, 2019
- Stem Cell Alopecia Treatment Market 2019 Business Growth, Size and Comprehensive Research Study Forecast to 2026 - Montana Ledger - December 8th, 2019
- Jasper Therapeutics launches out of Stanford with new approach to stem cell treatment - Endpoints News - December 7th, 2019
- MaaT Pharma Announces the Presentation of Positive Data with Its Lead Microbiome Biotherapeutic in Intestinal-Predominant Acute... - December 7th, 2019
- Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers - GlobeNewswire - December 7th, 2019
- Sickle Cell Anemia Patient Becomes First Person in the US to Have Her Genes Edited With CRISPR - Interesting Engineering - December 7th, 2019
- Teen diagnosed with cancer again just months after being told he beat disease - Mirror Online - December 7th, 2019
- Living with cancer: 'Exercising during my chemotherapy treatment worked wonders' - inews - December 7th, 2019
- Takeda to Present Results from the Phase 3 TOURMALINE-AL1 Trial of NINLARO in Patients with Amyloidosis - Business Wire - December 7th, 2019
- Stem cells may trigger immune repair to mend hearts - BioNews - December 5th, 2019
- Omeros Reports Positive Data Across Primary and Secondary Endpoints in Pivotal Trial of Hematopoietic Stem Cell Transplant-Associated Thrombotic... - December 5th, 2019
- Hunter Syndrome Treatment Market Size, Share & Trend Analysis By Treatment, By Region And Segment Forecasts, 2019 - 2026 - P&T Community - December 5th, 2019
- Platelet Rich Plasma and Stem Cell Alopecia Treatment Market is on Course to Expand at a CAGR of XX% Over the Forecast Period 2018 - 2026 - Weekly Spy - December 5th, 2019
- miR-194 Inhibits the Proliferation of SW620 Colon Cancer Stem Cells Th | CMAR - Dove Medical Press - December 5th, 2019
- Stem Cell Therapy Market Growth opportunities, Trends, Industry Analysis, and Forecast to 2020 - Kentucky Reports - December 5th, 2019
- As per new Study on Stem Cell Therapy Market 2019 Future Strategy, Analysis and Prediction by Leading Manufacturers, its Application and Types... - December 5th, 2019
- Stem Cell Therapy Market Size, Share, Trends, and Opportunity Analysis by 2017 - 2025 - The Market Expedition - December 5th, 2019
- Newly approved sickle cell drug ushers in an era of therapeutic breakthroughs - Worcester Telegram - December 5th, 2019
- A new stem cell therapy promises to heal injured heart - TheHealthSite - December 5th, 2019
- Harnessing Gamma T Cells To Bring Effective Therapies to Patients - Technology Networks - November 30th, 2019
- Phase 2 Trial Data on ALS NurOwn Therapy, Supporting Safety And Early Efficacy, Published - ALS News Today - November 30th, 2019
- Proof-of-Concept Study of CAR-NK Cell Therapy with Engineered Persistence Shows Potential - Cancer Network - November 29th, 2019
- Mum shares heartbreaking photo of toddler sobbing through gruelling cancer treatment - The Sun - November 29th, 2019
- Mesenchymal Stem Cells Market Key Trends, Key Players, Challenges And Standardization, Analysis Of Key Players, And Forecast To 2026 - WindStreetz - November 29th, 2019
- Bone Therapeutics SA: Information on the total number of voting rights and shares - GlobeNewswire - November 29th, 2019
- Induction Therapy and Hematopoietic Stem Cell Transplantation for Mixed-Phenotype Acute Leukemia - Cancer Therapy Advisor - November 28th, 2019
- Why Stem Cell Therapy Might Be Your Answer To Chronic Pain - Patch.com - November 28th, 2019
- North-east toddler overcomes cancer after pioneering stem cell treatment - Press and Journal - November 28th, 2019
- Revolutionary stem cell banking and therapy from Celltex gives patients hope - KHOU.com - November 28th, 2019
- Kyoto University seeks approval to use stem cells in treatment for damaged knees - The Japan Times - November 28th, 2019
- Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy - Science Advances - November 28th, 2019
- Sickle Cell Disease: Current Treatment and Emerging Therapies - AJMC.com Managed Markets Network - November 28th, 2019
- Vertex plans major Boston expansion to support gene, cell therapy ambitions - FiercePharma - November 28th, 2019
- Discovery of 'Tendon Stem Cells' Could Revolutionize How We Recover From Injuries - Good News Network - November 28th, 2019
- You can take my Dads tweets over my dead body - TechCrunch - November 28th, 2019
- From Tiger Woods to Brooks Koepka, the 9 things we learned this fall on PGA Tour - Golf Channel - November 28th, 2019
- Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Future Growth, Industry Verticals, and Research Forecast upto 2026 - The Denton Chronicle - November 28th, 2019
- Stem Cell Therapy Market Gain Impetus due to the Growing Demand over 2025 - Guru Online News - November 28th, 2019
- Stem Cell Therapy Market Size, by Therapeutic Application (Musculoskeletal Disorders, Wounds and Injuries), by Cell Source (Adipose Tissue-derived... - November 28th, 2019
- Global Musculoskeletal Disorder Stem Cell Therapy Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2025 - Avon Lake Ledger - November 28th, 2019
- Translink in Armagh holding stem cell registration event in memory of Gavin McNaney - Armagh i - November 28th, 2019
- Induction Therapy and Hematopoietic Stem Cell Transplantation for Mixed-Phenotype Acute Leukemia - Hematology Advisor - November 25th, 2019
- Tendon stem cell discovery could lead to improvements in injury recovery - Drug Target Review - November 25th, 2019
- 2 Small-Cap Biotechs That Soared Last Week - Motley Fool - November 25th, 2019
- Cell Culture Market Size to Exceed US $42 Billion by 2026 - Post Register - November 25th, 2019